Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-02-16
2010-11-16
Carlson, Karen Cochrane (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
07833968
ABSTRACT:
Provided in the present application is a pharmaceutical composition for treating, preventing, or ameliorating a bone or cartilage condition and methods of making and using the same.
REFERENCES:
patent: 4394370 (1983-07-01), Jefferies
patent: 4409332 (1983-10-01), Jefferies et al.
patent: 5385887 (1995-01-01), Yim et al.
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5674725 (1997-10-01), Beertsen et al.
patent: 5674844 (1997-10-01), Kuberasampath et al.
patent: 5763416 (1998-06-01), Bonadio et al.
patent: 5854207 (1998-12-01), Lee et al.
patent: 5916870 (1999-06-01), Lee et al.
patent: 5942496 (1999-08-01), Bonadio et al.
patent: 5948428 (1999-09-01), Lee et al.
patent: 6077987 (2000-06-01), Breitbart et al.
patent: 6083690 (2000-07-01), Harris et al.
patent: 6200606 (2001-03-01), Peterson et al.
patent: 6352972 (2002-03-01), Nimni et al.
patent: 6413998 (2002-07-01), Petrie et al.
patent: 6462019 (2002-10-01), Mundy et al.
patent: 7052856 (2006-05-01), Ting
patent: 7544486 (2009-06-01), Ting et al.
patent: 2003/0143688 (2003-07-01), Fujiwara et al.
patent: 2006/0053503 (2006-03-01), Culiat et al.
patent: 2006/0111313 (2006-05-01), Ting
patent: 1 447 413 (2006-01-01), None
patent: WO 01/24821 (2001-04-01), None
patent: WO 2004/024893 (2004-03-01), None
patent: WO 2004/072100 (2004-08-01), None
Kuroda et al., “Biochemical Characterization and Expression Analysis of Neural Thrombospondin-1-like Proteins NELL1 and NELL2”, Biochem. and Biophysical Research Communications 265, pp. 79-86 (1999).
Kuroda et al., “Involment of Epidermal Growth Factor-like Domain of NELL Proteins in the Novel Protein-Protein Interaction with protein Kinase C”, Biochem. and Biophysical Research Communications 265, pp. 752-757 (1999).
Beck et al. “TGF-β1Induces Bone Closure of Skull Defects.” J. of Bone Miner. Res. vol. 6, No. 11:1257-1265 (1991).
Bellows et al., “Determination of Numbers of Osteoprogenitors Present in Isolated Fetal Rat Calvaria Cells in Vitro”, Developmental Biology, vol. 133, pp. 8-13 (1989).
Burger et al., “Octeoblast and Osteoclast Precursors in Primary Cultures of Calvarial Bone Cells”, Anat Rec. vol. 214 (1) pp. 32-40, Abstract only (1986).
Chen et al. “Structure, Chromosomal Localization, and Expression Pattern of the MurineMagpGene,” J. Biol Chem. vol. 268, No. 36: 27381-27389 (1998).
Crawford et al. “Thrombospondin-1 is a Major Activator of TGF-β1in Vivo.” Cell, vol. 93:1159-1170 (1998).
Francois and Bier “Xenopus chordin andDrosophilashort gastrulation Genes Encode Homologous Proteins Functioning in Dorsal-Ventral Axis Formation” Cell, vol. 80:19-20 (1995).
Gelbart, “Databases in Genomic Reseach”, Science, vol. 282, pp. 659-661 (1998).
Hoshi, K. et al., “Fibroblasts of Spinal Ligaments Pathologically Differentiate Into Chondrocytes Induced by Recombinant Human Bone Morphogenetic Protein-2: Morphological Examinations for Ossification of Spinal Ligaments”, Bone vol. 21, No. 2, pp. 155-162 (1997).
Kim et al., “NELL-1 Enhances Mineralization in Fetal Calvarial Osteoblastic Cells”, Plastic Surgery, Surgical Forum, pp. 599-601 (1999).
Kuroda et al., “Involvement of Epidermal Growth Factor-like Domain of NELL Proteins in the Novel Protein-Protein Interaction with Protein Kinase C1”, Biochemical and Biophysical Research Comm., vol. 265, pp. 752-757 (1999).
Kuroda et al., “Biochemical Characterization and Expression Analysis of Neural Thrombospondin-1-like Proteins NELL 1 and NELL 2”, Biochemical and Biophysical Research Comm. vol. 265, pp. 79-86 (1999).
Liu et al., “Simultaneous Detection of Multiple Bone-Related mRNAs and Protein Expression during Osteoblast Differentiation: Polymerase Chain Reaction and Immunocytochemical Studies at the Single Cell Level”, Developmental Biology, vol. 166, pp. 220-234 (1994).
Luce et al., “The neuronal EGF-related genes NELL1 and NELL2 are expressed in Hemopoietic cells and developmentally regulated in the B lineage”, Gene 231, pp. 121-126 (1999).
Opperman et al., “TGF-β1, TGF- β2, and TGF- β3 Exhibit Distinct Patterns of Expression During Cranial Suture Formation and Obliteration In Vivo and In Vitro”, Journal of Bone and Mineral Research, vol. 12, No. 3, pp. 301-310 (1997).
Piccolo et al. “Dorsoventral Patterning in Xenopus: Inhibition of Ventral Signals by Direct Binding of Chordin to BMP-4” Cell, vol. 86: 589-598 (1996).
Siris et al., “Design of NORA, the National Osteoporosis Risk Assessment Program: A Longitudinal US Registry of Postmenopausal Women”, Ostreoporos Int. Suppl. 1, pp. 62-69 (1998).
Takagi et al., “The reaction of the dura to bone morphogenetic protein (BMP) in repair of skull defects”, Ann Surg, vol. 196, No. 1, pp. 100-9. Abstract only (1982).
Takami et al., “Ca2+-ATPase Inhibitors and Ca2+-Ionophore Induce Osteoclast-like Cell Formation in the Cocultures of Mouse Bone Marrow Cells and Calvarial Cells”, Biochemical and Biophysical Research Comm., vol. 237, pp. 111-115 (1997).
Tieu et al., “Identification of Human NEL-2 Associated with Premature Suture Fusion”, J. Dent res. 77(A):635, Abstract Only (1998).
Ting et al., “Human NELL-1 Expressed in Unilateral Coronal Synostosis”, Journal of Bone and Mineral Research, vol. 14, No. 1, pp. 80-89 (1999).
Ting et al., “NELL 1 Enhances Mineralization in Fetal Calvarial Osteoblastic Cells”, J. Dent. Res. 79, p. 625, 3849, Abstract Only (2000).
Ting, K. et al. “NEL-2 Expressed in Unilateral Prematurely Fusing and Fused Coronal Sutures”, J. Dent Res. 77(B): 2224, Abstract Only (1998).
Ting et al. “NEL-2 Gene is associated with bone formation in Craniosynostosis”, Plastic Surgery, Surgical Forum 602-603 (no date).
Toriumi et al. “Mandibular Reconstruction With a Recombinant Bone-Inducing Factor.” Arch. Otolaryngol. Head Neck Surg. vol. 117: 1101-1112 (1991).
Watanabe et al. “Cloning and Characterization of Two Novel Human cDNAs (NELL1 and NELL2) Encoding Proteins with Six EGF-like Repeats”, Genomics 38, pp. 273-276 (1996).
Wobus, “Potential of Embryonic Stem Cells”, Molecular Aspects of Medicine 22, pp. 149-164 (2001).
Yasko et al. “The Healing of Segmental Bone Defects, Induced by Recombinant Human Bone Morphogenetic Protein (rhBMP-2).” J. of Bone and Joint Surgery vol. 74A, No. 5: 659-670 (1992).
Zhang et al., “NELL-1 Overexpression Transgenic Mice Simulate Human Craniosynostosis”, Surgical Forum, vol. 52, pp. 576-578 (2001).
Zhang et al., “Craniosynostosis in transgenic Mice Overexpressing Nell-1”, The Journal of Clinical Investigation, vol. 110. No. 6 pp. 861-870 (2002).
Supplementary European Search Report for PCT/US2006005473, mailed Dec. 8, 2008, 16 pgs.
Aghaloo et al., “Nell-1 induces bone marrow stromal cell differentiation and mineralization in vitro and bone formation in vivo”, J. of the Am Coll. Of Surgeons vol. 201, No. 3S, p. S45 (2005).
Cowan et al., “Nell-1 induces osteogenic differentiation and bone formation within calvarial defects”, J. of the Am Coll. Of Surgeons vol. 201, No. 3S, p. S61 (2005).
Cowan et al., “Nell-1 induced bone formation within the distracted intermaxillary suture” Bone, Pergamon press, vol. 38, No. 1, pp. 48-58 (2006).
Kuroda Shun'ichi
Soo Chia
Ting Kang
Wu Ben
Carlson Karen Cochrane
Squire Sanders & Dempsey L.L.P.
The Regents of the University of California
LandOfFree
Pharmaceutical compositions for treating or preventing bone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions for treating or preventing bone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions for treating or preventing bone... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4247777